| Aggregate Evidence Quality . | Expert Opinion, D . |
|---|---|
| Benefits | Avoidance of complications caused by rapid BP reduction |
| Risks, harm, cost | Severe BP elevation may persist |
| Benefit–harm assessment | Benefit outweighs harm |
| Intentional vagueness | None |
| Role of patient preferences | None |
| Exclusions | Patients without acute severe HTN and life-threatening symptoms |
| Strength | Weak recommendation because of expert opinion |
| Key references | 240,533,535 |
| Aggregate Evidence Quality . | Expert Opinion, D . |
|---|---|
| Benefits | Avoidance of complications caused by rapid BP reduction |
| Risks, harm, cost | Severe BP elevation may persist |
| Benefit–harm assessment | Benefit outweighs harm |
| Intentional vagueness | None |
| Role of patient preferences | None |
| Exclusions | Patients without acute severe HTN and life-threatening symptoms |
| Strength | Weak recommendation because of expert opinion |
| Key references | 240,533,535 |